Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvaro Gracia

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Clinical Rheumatology|April 28, 2019
Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practiceVivian P Bykerk, Andrew J K Östör, José Alvaro-Gracia, et al.
BMC Musculoskeletal Disorders|May 19, 2022
Prevalence of post-COVID-19 in patients with fibromyalgia: a comparative study with other inflammatory and autoimmune rheumatic diseasesJavier Rivera, Tamara Rodríguez, Marta Pallarés, et al.
Clinical Rheumatology|January 22, 2015
Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practiceVivian P Bykerk, Andrew J K Östör, José Alvaro-Gracia, et al.
Annals of the Rheumatic Diseases|May 23, 2012
Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practiceVivian P Bykerk, Andrew J K Ostör, José Alvaro-Gracia, et al.
Reumatologia Clinica|January 7, 2014
Practice guidelines for the use of subcutaneous abataceptEmilio Martín Mola, Alejandro Balsa, Víctor Martínez Taboada, et al.
Reumatologia Clinica|July 29, 2011
[Consensus on the Use of Rituximab in Rheumatoid Arthritis. A document with evidence-based recommendations. Grupo de Expertos en Rituximab. ]Emilio Martín Mola, Blanca Hernández, Miriam García-Arias, et al.
Arthritis and Rheumatism|December 31, 1998
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonistB Bresnihan, J M Alvaro-Gracia, M Cobby, et al.
Clinical and Experimental Rheumatology|March 18, 2021
Clinical impact of confinement due to the COVID-19 pandemic on patients with fibromyalgia: a cohort studyJavier Rivera, Isabel Castrejón, Laura Vallejo-Slocker, et al.
Reumatologia Clinica|January 30, 2019
Launch and preliminary analysis of Hospital de La Princesa's inter-specialists biological therapies unitJosé María Alvaro-Gracia, Miguel Arredondo, Esteban Daudén, et al.
Reumatologia Clinica|July 7, 2012
Abatacept use in rheumatoid arthritis: evidence review and recommendationsEmilio Martín Mola, Alejandro Balsa, Víctor Martínez Taboada, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Clinical Rheumatology|April 28, 2019
Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practiceVivian P Bykerk, Andrew J K Östör, José Alvaro-Gracia, et al.
BMC Musculoskeletal Disorders|May 19, 2022
Prevalence of post-COVID-19 in patients with fibromyalgia: a comparative study with other inflammatory and autoimmune rheumatic diseasesJavier Rivera, Tamara Rodríguez, Marta Pallarés, et al.
Clinical Rheumatology|January 22, 2015
Comparison of tocilizumab as monotherapy or with add-on disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and inadequate responses to previous treatments: an open-label study close to clinical practiceVivian P Bykerk, Andrew J K Östör, José Alvaro-Gracia, et al.
Annals of the Rheumatic Diseases|May 23, 2012
Tocilizumab in patients with active rheumatoid arthritis and inadequate responses to DMARDs and/or TNF inhibitors: a large, open-label study close to clinical practiceVivian P Bykerk, Andrew J K Ostör, José Alvaro-Gracia, et al.
Reumatologia Clinica|January 7, 2014
Practice guidelines for the use of subcutaneous abataceptEmilio Martín Mola, Alejandro Balsa, Víctor Martínez Taboada, et al.
Reumatologia Clinica|July 29, 2011
[Consensus on the Use of Rituximab in Rheumatoid Arthritis. A document with evidence-based recommendations. Grupo de Expertos en Rituximab. ]Emilio Martín Mola, Blanca Hernández, Miriam García-Arias, et al.
Arthritis and Rheumatism|December 31, 1998
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonistB Bresnihan, J M Alvaro-Gracia, M Cobby, et al.
Clinical and Experimental Rheumatology|March 18, 2021
Clinical impact of confinement due to the COVID-19 pandemic on patients with fibromyalgia: a cohort studyJavier Rivera, Isabel Castrejón, Laura Vallejo-Slocker, et al.
Reumatologia Clinica|January 30, 2019
Launch and preliminary analysis of Hospital de La Princesa's inter-specialists biological therapies unitJosé María Alvaro-Gracia, Miguel Arredondo, Esteban Daudén, et al.
Reumatologia Clinica|July 7, 2012
Abatacept use in rheumatoid arthritis: evidence review and recommendationsEmilio Martín Mola, Alejandro Balsa, Víctor Martínez Taboada, et al.
Pageof 4